MedPath
HSA Approval

DHACOCIN for injection 500mg/vial

SIN13745P

DHACOCIN for injection 500mg/vial

DHACOCIN for injection 500mg/vial

December 14, 2009

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01XA01

vancomycin

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited - Specialty Formulation Facility

Mylan Laboratories Limited - Sterile Product Division

Active Ingredients

Vancomycin Hydrochloride 512.571mg/vial equivalent to Vancomycin

500 mg

Vancomycin

Documents

Package Inserts

Dhacocin Injection PI.pdf

Approved: March 25, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.